Coya Therapeutics (COYA) Depreciation and Depletion (2022 - 2026)
Coya Therapeutics (COYA) reported Depreciation and Depletion of $2807.0 for Q1 2026, down 58.96% on a YoY basis from $6840.0 in Q1 2025, and down 58.97% sequentially from $6841.0 in Q4 2025.
Coya Therapeutics (COYA) Depreciation and Depletion (2022 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 5 years of Depreciation and Depletion data on file, last reported at $2807.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 58.96% year-over-year to $2807.0; the trailing twelve-month figure through Mar 2026 stood at $23328.0 (down 14.74% YoY), and the FY2025 full-year result was $27361.0, changed 0.0% from the prior year.
- Depreciation and Depletion fell to $2807.0 in Q1 2026, from $6841.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $12455.0 in Q3 2022 to a low of $2807.0 in Q1 2026.
- A 5-year average of $6603.0 and a median of $6840.0 in 2022 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion jumped 69.6% in 2023 and tumbled 58.96% in 2026, its largest moves.
- Tracing COYA's Depreciation and Depletion over 5 years: stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then grew by 0.01% to $6841.0 in 2025, then plunged by 58.97% to $2807.0 in 2026.
- Business Quant data shows COYA's Depreciation and Depletion at $2807.0 in Q1 2026, $6841.0 in Q4 2025, and $6840.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 39.39 Mn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | 2.20 Mn |
| 10 | Coya Therapeutics | 91.71 Mn | 40.98 Mn | - | 2,807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,807.00 |
| Mar 31, 2026 | 2,807.00 |
| Dec 31, 2025 | 6,841.00 |
| Dec 31, 2025 | 6,841.00 |
| Sep 30, 2025 | 6,840.00 |
| Sep 30, 2025 | 6,840.00 |
| Jun 30, 2025 | 6,840.00 |
| Jun 30, 2025 | 6,840.00 |
| Mar 31, 2025 | 6,840.00 |
| Mar 31, 2025 | 6,840.00 |
| Dec 31, 2024 | 6,840.00 |
| Dec 31, 2024 | 6,840.00 |
| Sep 30, 2024 | 6,841.00 |
| Sep 30, 2024 | 6,841.00 |
| Jun 30, 2024 | 6,840.00 |
| Jun 30, 2024 | 6,840.00 |
| Mar 31, 2024 | 6,840.00 |
| Mar 31, 2024 | 6,840.00 |
| Dec 31, 2023 | 6,840.00 |
| Dec 31, 2023 | 6,840.00 |